Critical Assessment of Angiogenesis Inhibitors in Clinical Trials

Abstract

Get full access to this article

View all access options for this article.

References

Scher

H.I.

, Heller

: Picking the winners in a sea of plenty. Clin Cancer Res, 8: 400–404, 2002.

Ratain

M.J.

, Stadler

W.M.

: Clinical trial designs for cytostatic agents. J Clin Oncol, 15: 19: 3154–3155, 2001.

Korn

E.L.

, Arbuck

S.G.

, Pluda

J.M.

, Simon

, Kaplan

R.S.

, Christian

M.C.

: Clinical trial designs for cytostatic agents: are new approaches needed? J Clin Oncol, 19: 265–272, 2001.

Eskens

FALM

, Verweij

: Clinical studies in the development of new anticancer agents exhibiting growth inhibition in models: facing the challenge of a proper study design. Crit Rev Oncol Hematol, 34: 83–88, 2000.